The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret
- 26 February 1997
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 321 (2) , 209-216
- https://doi.org/10.1016/s0014-2999(96)00950-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The broad‐spectrum anti‐emetic activity of the novel non‐peptide tachykinin NK1 receptor antagonist GR203040British Journal of Pharmacology, 1995
- Rational design of high affinity tachykinin NK1 receptor antagonistsBioorganic & Medicinal Chemistry, 1994
- Chromodacryorrhea and repetitive hind paw tapping: models of peripheral and central tachykinin NK1 receptor activation in gerbilsEuropean Journal of Pharmacology, 1994
- Delayed emesis following high-dose cisplatin: A double-blind randomised comparative trial of ondansetron (GR 38032F) versus placeboEuropean Journal Of Cancer, 1993
- Anti-emetic profile of a non-peptide neurokinin NK1 receptor antagonist, CP-99,994, in ferretsEuropean Journal of Pharmacology, 1993
- Characterisation of the tachykinin-induced hindlimb thumping response in gerbilsNeuropeptides, 1993
- 5-HT3 Receptor AntagonistsDrugs, 1991
- The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694British Journal of Cancer, 1988
- Neuropharmacology of emesis induced by anti-cancer therapyTrends in Pharmacological Sciences, 1988
- Pharmacologic Treatment of Chemotherapy-Induced Nausea and VomitingCancer Investigation, 1984